Application
Fig1: Protein: intestinal(mouse) lysate at 40ug; Primary: rabbit Anti-DFNA5 (ER1907-34) at 1:300; Secondary: HRP conjugated Goat-Anti-rabbit IgG(bs-0295G-HRP) at 1: 5000; Predicted band size: 54 kD Observed band size: 54 kDApplication
Fig2: Sample: Small intestine (Mouse) Lysate at 40 ug Primary: Anti- DFNA5 (ER1907-34) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 54 kD Observed band size: 54 kD| Product Name | DFNA5 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | 2310037D07Rik 4932441K13Rik Deafness, autosomal dominant 5 Deafness, autosomal dominant 5 protein DFNA5 DFNA5 gene DFNA5_HUMAN Dfna5h EG14210 Fin15 ICERE 1 ICERE-1 Inversely correlated with estrogen receptor expression 1 Non-syndromic hearing impairment protein 5 Nonsyndromic hearing impairment protein. |
| Immunogen | KLH conjugated synthetic peptide derived from human DFNA5 21-120/496 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500-2000: |
|
| Species Reactivity | HumanMouseRatDogCowSheep |
| Concentration | 1mg/ml |
| Alternative Names | 2310037D07Rik
4932441K13Rik
Deafness autosomal dominant 5 Deafness autosomal dominant 5 protein DFNA5 DFNA5 gene DFNA5_HUMAN Dfna5h EG14210 Fin15 ICERE 1 ICERE-1 Inversely correlated with estrogen receptor expression 1 Non-syndromic hearing impairment protein 5 Nonsyndromic hearing impairment protein. |
|---|---|
| Molecular Weight(MW) | 54 KDa |
| SwissProt ID | O60443 |
|---|
Application
Fig1: Protein: intestinal(mouse) lysate at 40ug; Primary: rabbit Anti-DFNA5 (ER1907-34) at 1:300; Secondary: HRP conjugated Goat-Anti-rabbit IgG(bs-0295G-HRP) at 1: 5000; Predicted band size: 54 kD Observed band size: 54 kD
Application
Fig2: Sample: Small intestine (Mouse) Lysate at 40 ug Primary: Anti- DFNA5 (ER1907-34) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 54 kD Observed band size: 54 kD| Positive Control | Expressed in cochlea. Low level of expression in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas, with highest expression in placenta. |
|---|---|
| Application Notes | WB:1:500-2000: |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
